What does Idylla® mean for cancer patients?

Idylla® provides accurate, actionable results with direct impact on treatment choice.

• IdyllaTM solid biopsy assays focus on clinically relevant mutations
• Clear reporting
• According to clinical guidelines of ASCO, ESMO, NCCN and IASLC

Therapeutic area Genes Clinically Relevant Mutations
Melanoma BRAF 7 mutations in codon 600
Colorectal Cancer KRAS NRAS BRAF 21 mutations in codons 12, 13, 59, 61, 117, 146
18 mutations in codons 12, 13, 59, 61, 117, 146
5 mutations in codon 600
Lung cancer EGFR 51 mutations in exons 18, 19, 20, 21

Why wait weeks instead of days?

From sample to treatment initiation in 1-2 days.

Molecular testing

Traditional Way Idylla® Way
In or outside your hospital
  • sending out samples
  • molecular infrastructure
  • molecular lab technicians
In your hospital
  • in-house testing
  • any laboratory setting
  • all lab technicians
1-4 days turnaround time of test

cumbersome workflow/manual steps

< 2.5 hours turnaround time of test

fully automated

grouping of patient samples

1/week or bi-weekly

individual patient sample

on demand

from sample treatment to initiation

on average 18 days

from sample treatment to initiation

in 1-2 days